Concepedia

Monserrat Llaguno‐Munive

ML

9

Publications

166

Citations

9

H-Index

2013

Active since

Affiliations

Instituto Nacional de Cancerología(Current)

Universidad Nacional Autónoma de México

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine

Vall d'Hebron Hospital Universitari

Vall d'Hebron Institut de Recerca

Monserrat Llaguno‐Munive is an author at Instituto Nacional de Cancerología specializing in radiation oncology, engineering, and nanomedicine.

ORCID

Top concepts

Publications per year

2013–2025

9

Publications

9

Smart and eco-friendly N-isopropylacrylamide and cellulose hydrogels as a safe dual-drug local cancer therapy approach

Fernanda Andrade, María Mercé Roca-Melendres, Monserrat Llaguno‐Munive et al. · Carbohydrate Polymers · 2022 · 26 citations

, , +8

Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide

Monserrat Llaguno‐Munive, Sebastián León-Zetina, Inés Vázquez‐López et al. · Frontiers in Oncology · 2020 · 24 citations · Full text

Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma

Monserrat Llaguno‐Munive, Mario Romero-Piña, Janeth Serrano‐Bello et al. · Cancers · 2018 · 23 citations · Full text

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Monserrat Llaguno‐Munive, Luis A. Medina, Rafael Jurado et al. · Cancer Cell International · 2013 · 18 citations · Full text

Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment

Julio Mena-Hernández, Helgi Jung–Cook, Monserrat Llaguno‐Munive et al. · AAPS PharmSciTech · 2020 · 18 citations

, , +13

Rows per page

1–5 of 9